1. Home
  2. ALVO vs OMCL Comparison

ALVO vs OMCL Comparison

Compare ALVO & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alvotech

ALVO

Alvotech

SELL

Current Price

$4.29

Market Cap

1.7B

Sector

Health Care

ML Signal

SELL

Logo Omnicell Inc. ($0.001 par value)

OMCL

Omnicell Inc. ($0.001 par value)

SELL

Current Price

$34.47

Market Cap

1.6B

Sector

Technology

ML Signal

SELL

Company Overview

Basic Information
Metric
ALVO
OMCL
Founded
2013
1992
Country
Luxembourg
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Manufacturing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
2021
2000

Fundamental Metrics

Financial Performance
Metric
ALVO
OMCL
Price
$4.29
$34.47
Analyst Decision
Buy
Strong Buy
Analyst Count
7
8
Target Price
$7.50
★ $57.43
AVG Volume (30 Days)
★ 904.9K
558.7K
Earning Date
11-11-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 1.01
Revenue
N/A
★ $787,309,000.00
Revenue This Year
$10.60
$3.69
Revenue Next Year
$22.47
$0.92
P/E Ratio
★ $18.20
$35.09
Revenue Growth
N/A
★ 9.93
52 Week Low
$2.94
$31.75
52 Week High
$6.53
$51.84

Technical Indicators

Market Signals
Indicator
ALVO
OMCL
Relative Strength Index (RSI) 39.19 42.43
Support Level $3.10 $32.11
Resistance Level $4.59 $36.63
Average True Range (ATR) 0.29 1.67
MACD -0.02 -0.35
Stochastic Oscillator 16.48 4.85

Price Performance

Historical Comparison
ALVO
OMCL

About ALVO Alvotech

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

About OMCL Omnicell Inc. ($0.001 par value)

Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.

Share on Social Networks: